Sheridan, Wyoming, 5 June 2025 (Globe Newswire) – Bytebrain LLC, an emerging AI research and consultancy firmhas announced the launch of MedrolAn intelligent platform that is designed to help pharmaceutical companies to walk faster, safer and more adaptive clinical tests.
Bytebrain
Medrail, shortly before Medicalforcement-based agent intelligence for lifesciencesBrings together the power of artificial intelligence and advanced compliance automation to modernize the clinical test process. The company has requested an American patent under the USPTO Track One program to speed up the protection of the new technology of the platform.
Priyanshu Sharma, co-founder of Bytebrain
“Clinical examinations are often slow, expensive and difficult to manage, especially in rapidly evolving medical landscapes,” said Priyanshu sharmaCo-founder of Bytebrain. “Medical helps organizations to respond to safety data faster, reduce manual errors and to maintain global regulatory standards.”
A smarter way to perform clinical tests
Medrail uses a team of specialized AI agents, each trained to process tasks such as the recruitment of patients, protocol surveillance, safety monitoring and documentation compliance. These agents work together in real time and adapt to test data and new legal guidelines as they arise.
Priyanshi bhatnagar, co-founder of Bytebrain
“What makes Mediek unique is the built -in safety verification and explanation,” added Priyanshi bhatnagarCo-founder. “Any protocol change, every recommendation, is supported by formal logic, transparent reasoning and a full audit track.”
Main benefits of Medical:
- Faster protocol design and changes
- Early detection of safety problems using AI
- Built-in compliance from FDA, Hipaa and ICH-GCP standards
- Automated documentation with full audit logs
- Seamless integration with existing clinical workflows
Why it matters
Clinical tests can cost up to $ 3 billion per approved medicine and take more than a decade to complete. Bytebrain is of the opinion that smarter, AI-assisted test systems that can considerably shorten time, possibly save millions and speed up time-to-market for life-saving therapies.
The platform has been developed with input from clinical research experts in pharmaceutical, academic medical centers and regulatory issues. The first feedback was positive, with Bytebrain preparing in the coming months for releasing technical articles and pilot studies.
About Bytebrain
Bytebrain LLC is a Research-First AI company that specializes in complex, regulated industries. Established in the US combines advisory services with the development of advanced IP in Healthcare, Finance and Enterprise AI systems. Medrail is the HealthTech Innovation flagship of the company and part of its broader mission to build AI solutions for compliance with people.
